Stock listing

Stuttgart:WAZ Waters Corporation Aktie

German listing (Stuttgart) of Waters Corporation · home listing NYSE:WAT

Follow Waters Corporation into a list and get an email when it puts out news.

Home listing price · NYSE:WAT

$440.45 USD -25.65 (-5.5%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:WAT

Past year +16.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$437.54 – $455.14 USDNov 20, 2026
Volume
1.35M sharesNov 20, 2026
Market cap
$43.29B USDAt the close on Nov 20, 2026 · price × 98.29M shares outstanding
52-week range
$282.77 – $483.33 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$364.5M USDMedian day 776,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Waters Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:WAT · Home$440.45 USD-25.65 (-5.5%)1,353,532$454.35$455.14$437.54$466.10Close on Nov 20, 2026
B3:WATC34476.58 BRL0.00 (0.0%)—476.58476.58476.58476.58Close on Nov 19, 2026
LSE:0LTI$441.98 USD-18.50 (-4.0%)849$453.00$457.77$441.98$460.48Close on Nov 20, 2026
Dusseldorf:WAZ€403.80 EUR-12.60 (-3.0%)—€412.00€414.20€403.20€416.40Close on Nov 20, 2026
Frankfurt:WAZ€413.20 EUR-9.00 (-2.1%)1€413.20€413.20€413.20€422.20Close on Nov 20, 2026
Munich:WAZ€412.60 EUR-15.00 (-3.5%)—€414.80€414.80€412.60€427.60Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:WAT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$440.45-25.65-5.5%$454.35$455.14$437.541,353,532
$466.10+16.32+3.6%$453.14$466.46$449.62734,151
$449.78-3.64-0.8%$452.04$458.33$447.97584,265
$453.42-6.83-1.5%$455.12$460.05$451.61575,393
$460.25-1.95-0.4%$464.17$465.04$454.72521,838
$462.20-8.70-1.8%$465.00$470.10$459.99557,625
$470.90-4.62-1.0%$479.25$483.33$470.65651,757
$475.52-1.18-0.2%$470.00$480.05$467.72889,323
$476.70+19.10+4.2%$463.49$480.32$457.571,137,439
$457.60+4.52+1.0%$450.61$463.91$450.61695,686
$453.08-14.52-3.1%$465.66$466.06$451.801,149,608
$467.60+7.70+1.7%$470.13$472.68$455.291,086,241
$459.90+10.37+2.3%$456.61$474.29$449.511,793,365
$449.53-13.19-2.9%$463.67$466.45$446.001,943,609
$462.72-17.35-3.6%$479.04$479.60$458.851,342,305
$480.07+3.19+0.7%$479.23$482.27$472.60882,967
$476.88+8.33+1.8%$468.02$482.28$465.30872,491
$468.55+12.57+2.8%$454.83$470.85$452.35797,335
$455.98+2.31+0.5%$455.98$461.55$449.85909,069
$453.67-1.92-0.4%$458.16$458.16$446.70907,600
$455.59-1.88-0.4%$459.48$465.36$449.091,267,700
$457.47+14.64+3.3%$436.90$459.63$435.07952,400
$442.83+8.56+2.0%$434.37$448.03$427.97776,700
$434.27-2.68-0.6%$436.55$441.28$433.27468,800
$436.95-7.20-1.6%$444.48$448.39$431.99902,000
$444.15+7.54+1.7%$440.37$449.12$435.791,008,600
$436.61+7.44+1.7%$430.88$441.89$429.90901,400
$429.17-2.93-0.7%$435.00$436.53$422.831,066,800
$432.10-1.67-0.4%$433.73$435.07$426.50913,500
$433.77+4.64+1.1%$429.20$437.53$428.191,119,600
$429.13-6.86-1.6%$431.70$432.46$421.611,043,900
$435.99-0.44-0.1%$436.00$440.37$427.41770,900
$436.43-3.69-0.8%$445.74$454.54$431.621,056,700
$440.12+14.91+3.5%$425.61$440.79$423.031,007,400
$425.21-0.32-0.1%$426.78$433.34$423.44625,600
$425.53-13.86-3.2%$437.21$438.03$424.70810,700
$439.39-3.87-0.9%$443.26$448.21$439.19665,900
$443.26+0.32+0.1%$441.46$444.41$437.88625,600
$442.94+9.40+2.2%$427.27$445.48$423.89981,500
$433.54+3.24+0.8%$428.71$435.93$425.67662,500
$430.30+9.73+2.3%$418.33$436.34$418.001,031,400
$420.57-5.17-1.2%$428.17$430.00$420.00743,600
$425.74+1.82+0.4%$424.13$433.09$422.83648,300
$423.92+2.29+0.5%$425.80$427.76$420.75782,400
$421.63-8.09-1.9%$429.23$430.64$420.801,035,000
$429.72+11.08+2.6%$424.00$431.78$422.06688,800
$418.64+1.55+0.4%$417.86$424.73$415.94710,800
$417.09+7.08+1.7%$413.98$421.23$411.89825,200
$410.01+1.67+0.4%$411.66$411.66$402.13728,800
$408.34+6.70+1.7%$406.47$410.11$403.77487,200
$401.64-3.17-0.8%$397.57$403.49$392.95572,700
$404.81+1.90+0.5%$403.83$411.86$400.95755,200
$402.91-6.47-1.6%$405.33$407.42$399.72419,500
$409.38-4.18-1.0%$408.66$412.10$402.83352,100
$413.56+1.36+0.3%$415.91$418.56$404.51438,300
$412.20+6.36+1.6%$404.56$416.58$404.51621,500
$405.84-8.79-2.1%$415.31$424.46$404.24517,200
$414.63-0.060.0%$405.99$415.83$405.99679,200
$414.69-6.57-1.6%$417.80$422.50$412.38435,100
$421.26+7.09+1.7%$420.00$426.22$417.20741,500
$414.17-0.27-0.1%$409.75$418.48$406.87426,600
$414.44+3.69+0.9%$412.24$414.90$407.12631,818
$410.75+0.050.0%$406.45$411.20$401.60600,298
$410.70+6.01+1.5%$400.64$412.95$396.00816,900
$404.69-11.15-2.7%$410.00$421.74$403.431,233,800

Splits

2 splits since 1999 · NYSE:WAT · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
2-for-1Split
Ticker
Stuttgart:WAZ
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Stuttgart
Currency
EUR

What changed lately

Latest news

All Waters Corporation news

Waters Corporation on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
35 in the last 12 months · 54 in all · newest Nov 17, 2026 · oldest 2025
Calls
27 calls with a replay · 27 with a transcript · latest Nov 3, 2026
Decks
44 decks · latest Nov 3, 2026

Where Waters Corporation is listed

ListingExchangeCountryCurrency
NYSE:WAT · Home listingNYSEUnited StatesUSD
gettex:WAZgettexGermanyEUR
BMV:WATBMVMexicoMXN
B3:WATC34B3BrazilBRL
LS Exchange:898123LS ExchangeGermanyEUR
Lang & Schwarz:898123Lang & SchwarzGermanyEUR
LSE:0LTILSEUnited KingdomUSD
Tradegate:WAZTradegateGermanyEUR
BIVA:WATBIVAMexicoMXN
Dusseldorf:WAZDusseldorfGermanyEUR
Frankfurt:WAZFrankfurtGermanyEUR
Munich:WAZMunichGermanyEUR
Milan:1WATMilanItalyEUR
Stuttgart:WAZ · This pageStuttgartGermanyEUR
BOATS:WATBOATSUnited StatesUSD
BX Swiss:WAZBX SwissSwitzerlandCHF
Hamburg:WAZHamburgGermanyEUR
Hanover:WAZHanoverGermanyEUR
VIE:WTRSViennaAustriaEUR
Xetra:WAZXetraGermanyEUR

Valuation

P/E 441× against a median of 32.2×: the highest of 9 Diagnostics & research services companies shown. Statements: 4 quarters to Oct 3, 2026 · price Nov 20, 2026

Enterprise value
$47.18B USD
P/E
441×
EV/sales
8.4×
EV/EBITDA
49.4×
Price/book
2.8×
Gross margin
49.4%
Operating margin
4.7%
Net margin
1.8%
Debt to equity
0.3×
Beta vs S&P 500
0.97

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Waters Corporation · NYSE:WATUS$43.29BUS$47.18B441×8.4×49.4×2.8×1.8%0.3×0.97
Lonza Group AG · SIX:LONNUS$54.17BUS$58.55B47.9×7.5×26.1×5.6×14.5%0.5×n/a
IDEXX Laboratories, Inc. · NASDAQ:IDXXUS$53.28BUS$53.45B45.1×11.5×n/a28.5×25.4%0.2×0.77
WuXi AppTec Co., Ltd. Class A · SSE:603259US$52.27BUS$44.51B13.2×5.1×n/a3.6×45.5%0.0×n/a
Agilent Technologies, Inc. · NYSE:AUS$48.04BUS$50.23B33.4×6.8×n/a6.5×19.5%0.5×0.87
Samsung Biologics Co., Ltd. · KRX:207940US$46.86BUS$45.66B31.8×13.5×22.2×7.5×43.6%0.1×n/a
IQVIA Holdings, Inc. · NYSE:IQVUS$40.51BUS$54.16B29.1×3.1×15.8×6.1×8.1%2.4×0.70
Natera, Inc. · NASDAQ:NTRAUS$39.64BUS$38.79Bn/a13.3×n/a21.2×−5.7%0.1×1.34
Illumina, Inc. · NASDAQ:ILMNUS$29.15BUS$27.82B32.6×n/an/a9.3×n/a0.0×1.14
Wuxi Biologics (Cayman) Inc. · HKEX:2269US$21.51BUS$19.96B29.2×6.1×15.9×3.0×22.5%0.1×n/a
Guardant Health, Inc. · NASDAQ:GHUS$19.73BUS$20.20Bn/a15.8×n/an/a−37.9%n/a1.16
Median of the othersUS$43.69BUS$45.09B32.2×7.5×19.0×6.5×19.5%0.1×1.00

Forecasts

15 strong buy · 3 buy · 5 hold · 1 sell · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
503.29 USD · Analysts' mean
EPS, year to Dec 2026
14.67 · 23 analysts
Revenue, year to Dec 2026
6.49B · 21 analysts

Team and board

Officers

OfficerRole
Fraser McLeodChief Executive Officer
Amol ChaubalSVP & Chief Financial Officer
Pearl S. HuangPresident, Dunad Therapeutics
Udit BatraPresident
Keeley AlemanSVP, General Counsel and Head of Global Human Resources
Caspar TudorHead of Investor Relations
Allan JaenickeSVP, Transformation
Brook ColangeloSVP & Chief Information Officer
Daniel RushSVP, Global Research & Strategy
Jianqing BennettSVP, Waters Advanced Diagnostics Division
Joyce YoonSVP, Waters Materials Sciences Division
Kristen GarveySVP, Global Communications
Mark GladwellSVP, Global Operations
Steve ConlySVP, Waters Biosciences Division
Tina WuSVP, Waters Analytical Sciences Division

Board

DirectorRole
Flemming ØrnskovChair of the Board
Claire M. FraserDirector

Events

Calls

CallWhenStatus
Waters (NYSE:WAT) Q3 2026 Earnings CallTue, Nov 03, 2026 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q2 2026 Earnings CallTue, Aug 04, 2026 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q1 2026 Earnings CallTue, May 05, 2026 · 8:30 AM ETReplay
Waters (NYSE:WAT) Q4 2025 Earnings CallMon, Feb 09, 2026 · 8:30 AM ETReplay
Waters (NYSE:WAT) Q3 2025 Earnings CallTue, Nov 04, 2025 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q2 2025 Earnings CallMon, Aug 04, 2025 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q1 2025 Earnings CallTue, May 06, 2025 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q4 2024 Earnings CallWed, Feb 12, 2025 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q3 2024 Earnings CallFri, Nov 01, 2024 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q2 2024 Earnings CallWed, Jul 31, 2024 · 8:00 AM ETReplay
All 27 calls
CallWhenStatus
Waters (NYSE:WAT) Q1 2024 Earnings CallTue, May 07, 2024 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q4 2023 Earnings CallTue, Feb 06, 2024 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q3 2023 Earnings CallTue, Nov 07, 2023 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q2 2023 Earnings CallWed, Aug 02, 2023 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q1 2023 Earnings CallTue, May 09, 2023 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q4 2022 Earnings CallWed, Feb 15, 2023 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q3 2022 Earnings CallTue, Nov 01, 2022 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q2 2022 Earnings CallTue, Aug 02, 2022 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q1 2022 Earnings CallTue, May 03, 2022 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q4 2021 Earnings CallTue, Feb 01, 2022 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q3 2021 Earnings CallTue, Nov 02, 2021 · 8:00 AM ETReplay
Waters (NYSE:WAT) Q2 2021 Earnings CallTue, Aug 03, 2021Replay
Waters (NYSE:WAT) Q1 2021 Earnings CallWed, May 05, 2021Replay
Waters (NYSE:WAT) Q4 2020 Earnings CallTue, Feb 02, 2021Replay
Waters (NYSE:WAT) Q3 2020 Earnings CallTue, Oct 27, 2020Replay
Waters (NYSE:WAT) Q2 2020 Earnings CallTue, Jul 28, 2020Replay
Waters (NYSE:WAT) Q1 2020 Earnings CallTue, Apr 28, 2020Replay

Results days

QuarterResultsShare move
Q3 2026Nov 3, 2026 · Before open+2.3%
Q2 2026Aug 4, 2026 · Before open+5.7%
Q1 2026May 5, 2026 · Before open+13.5%
Q4 2025Feb 9, 2026 · Before open−13.9%
Q3 2025Nov 4, 2025 · Before open+6.3%
Q2 2025Aug 4, 2025 · Before open−1.6%
Q1 2025May 6, 2025 · Before open−2.7%
Q4 2024Feb 12, 2025 · Before open−5.8%
Q3 2024Nov 1, 2024 · Before open+19.8%
Q2 2024Jul 31, 2024 · Before open+2.6%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · Before open+1.9%
Q4 2023Feb 6, 2024 · Before open+1.7%
Q3 2023Nov 7, 2023 · Before open+3.4%
Q2 2023Aug 2, 2023 · Before open+6.3%
Q1 2023May 9, 2023 · Before open−6.7%
Q4 2022Feb 15, 2023 · Before open−0.7%
Q3 2022Nov 1, 2022 · Before open+2.8%
Q2 2022Aug 2, 2022 · Before open−6.8%
Q1 2022May 3, 2022 · Before open+8.1%
Q4 2021Feb 1, 2022 · Before open+1.1%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings30 slidesNov 3, 2026
Q2 2026 Earnings PresentationEarnings33 slidesAug 4, 2026
Q1 2026 Earnings PresentationEarnings29 slidesMay 5, 2026
Q4 2025 Earnings PresentationEarnings22 slidesFeb 9, 2026
J.P. Morgan 44th Annual Healthcare Conference (January 2026)Conference29 slidesJan 12, 2026
J.P. Morgan 43rd Annual Healthcare Conference (November 2025)Conference38 slidesNov 11, 2025
Q3 2025 Earnings PresentationEarnings18 slidesNov 4, 2025
Q2 2025 Earnings PresentationEarnings21 slidesAug 4, 2025
Merger or Acquisition (July 2025)Merger or acquisition24 slidesJul 14, 2025
Merger or Acquisition (July 2025)Merger or acquisition36 slidesJul 14, 2025
All 44 decks
DeckKindSlidesDate
Merger or Acquisition (July 2025)Merger or acquisition7 slidesJul 14, 2025
Q1 2025 Earnings PresentationEarnings15 slidesMay 6, 2025
Investor Day (March 2025)Investor day87 slidesMar 5, 2025
Q4 2024 Earnings PresentationEarnings22 slidesFeb 12, 2025
J.P. Morgan 43rd Annual Healthcare Conference (January 2025)Conference38 slidesJan 13, 2025
Q3 2024 Earnings PresentationEarnings17 slidesNov 1, 2024
Q2 2024 Earnings PresentationEarnings17 slidesJul 31, 2024
Q1 2024 Earnings PresentationEarnings14 slidesMay 7, 2024
Q4 2023 Earnings PresentationEarnings23 slidesFeb 6, 2024
J.P. Morgan 42nd Annual Healthcare Conference (January 2024)Conference28 slidesJan 9, 2024
Q3 2023 Earnings PresentationEarnings17 slidesNov 7, 2023
Q2 2023 Earnings PresentationEarnings16 slidesAug 2, 2023
Q1 2023 Earnings PresentationEarnings16 slidesMay 9, 2023
Q4 2022 Earnings PresentationEarnings23 slidesFeb 15, 2023
J.P. Morgan 41st Annual Healthcare Conference (January 2023)Conference28 slidesJan 9, 2023
Q3 2022 Earnings PresentationEarnings18 slidesNov 1, 2022
Q2 2022 Earnings PresentationEarnings15 slidesAug 2, 2022
Investor Day (May 2022)Investor day83 slidesMay 19, 2022
Q1 2022 Earnings PresentationEarnings17 slidesMay 3, 2022
Q4 2021 Earnings PresentationEarnings18 slidesFeb 1, 2022
J.P. Morgan 40th Annual Healthcare Conference (January 2022)Conference22 slidesJan 10, 2022
Q3 2021 Earnings PresentationEarnings14 slidesNov 2, 2021
Q2 2021 Earnings PresentationEarnings15 slidesAug 3, 2021
J.P. Morgan 39th Annual Healthcare Conference (January 2021)Conference22 slidesJan 12, 2021
Technical Presentation (2020)Technical4 slides2020
Investor Day (March 2017)Investor day169 slidesMar 2, 2017
Technical Presentation (October 2016)Technical52 slidesOct 11, 2016
Postnova Analytics — Technical Presentation (September 2016)Technical27 slidesSeptember 2016
Technical Presentation (May 2013)Technical57 slidesMay 2013
Technical Presentation (2013)Technical79 slides2013
Technical Presentation (2013)Technical40 slides2013
Technical Presentation (May 2012)Technical47 slidesMay 22, 2012
Technical Presentation (2012)Technical53 slides2012
Technical Presentation (2011)Technical24 slides2011

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue3.17B2.96B2.96B2.97B2.79B2.37B2.41B2.42B2.31B2.17B
Cost of revenue1.29B1.20B1.20B1.25B1.16B1.01B1.01B992.6M947.1M891.5M
Gross profit1.83B1.76B1.76B1.72B1.63B1.36B1.40B1.43B1.36B1.28B
Research and development195.7M183.0M174.9M176.2M168.4M140.8M143.0M143.4M132.6M125.2M
Selling, general and administrative830.4M690.1M736.0M658.0M627.0M553.7M534.8M536.9M544.4M512.3M
Operating income802.6M826.4M817.7M873.4M821.7M645.5M708.5M739.8M662.2M625.0M
Depreciation and amortization88.1M87.0M84.6M72.0M71.6M68.7M53.8M58.0M61.5M51.7M
EBITDA890.7M913.4M902.3M945.4M893.3M714.2M762.3M797.7M723.6M676.7M
Interest expense69.5M89.7M98.9M48.8M44.9M49.1M48.7M48.6M56.8M44.9M
Income before tax754.9M754.9M736.2M837.8M806.2M610.9M678.2M682.1M641.1M600.1M
Income tax112.2M117.0M94.0M130.1M113.3M89.3M86.0M88.4M620.8M78.6M
Net income642.6M637.8M642.2M707.8M692.8M521.6M592.2M593.8M20.3M521.5M
Earnings per share, basic10.8010.7510.8711.8011.258.408.767.710.256.46
Earnings per share, diluted10.7610.7110.8411.7311.178.368.697.650.256.41

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents588.0M325.4M395.1M480.5M501.2M436.7M335.7M796.3M642.3M505.6M
Short-term investments934.0K898.0K862.0K68.1M6.45M1.43M938.9M2.75B2.31B
Receivables829.0M733.4M702.2M722.9M612.6M573.3M587.7M568.3M533.8M489.3M
Inventory572.0M477.3M516.2M455.7M356.1M304.3M320.6M291.6M270.3M262.7M
Current assets2.15B1.67B1.75B1.76B1.63B1.40B1.31B2.66B4.27B3.64B
Property, plant and equipment642.0M651.2M639.1M582.2M547.9M494.0M417.3M343.1M349.3M337.1M
Goodwill1.34B1.30B1.31B430.3M437.9M444.4M356.1M355.6M359.8M352.1M
Total assets5.08B4.55B4.63B3.28B3.09B2.84B2.56B3.73B5.32B4.66B
Accounts payable104.0M99.9M84.7M93.3M96.8M72.2M49.0M68.2M64.5M67.7M
Current liabilities1.24B789.8M789.6M785.7M680.5M805.0M591.3M448.9M606.2M520.3M
Long-term debt947.0M1.63B2.31B1.52B1.51B1.21B1.58B1.15B1.90B1.70B
Total debt1.41B1.63B2.36B1.58B1.52B1.36B1.69B1.15B1.90B1.83B
Total liabilities2.52B2.73B3.48B2.78B2.73B2.61B2.77B2.16B3.09B2.36B
Shareholders' equity2.56B1.83B1.15B504.5M367.6M232.1M-216.3M1.57B2.23B2.30B
Shares outstanding59.5M59.4M59.2K59.1M60.7M62.3M62.6M73.1M79.3M80.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations652.6M762.1M602.8M611.7M747.3M790.5M643.1M604.4M697.6M642.9M
Capital spending-112.7M-142.5M-160.6M-183.5M-168.3M-172.4M-163.8M-127.6M-90.5M-95.0M
Free cash flow539.8M619.6M442.2M428.2M579.0M618.1M479.3M476.9M607.2M534.1M
Cash from investing-152.3M-143.1M-1.44B-108.0M-231.6M-264.1M768.8M1.68B-535.8M-487.9M
Cash from financing-237.2M-696.7M755.0M-509.6M-438.3M-440.5M-1.87B-2.12B-63.9M-115.7M
Dividends paid-1.56B-42.8M-55.6M-66.0M-53.7M00
Share buybacks-14.7M-13.5M-70.3M-626.1M-648.9M-196.4M-2.47B-1.32B-332.5M-325.8M
Change in cash262.5M-69.7M-85.5M-20.7M64.5M101.0M-460.6M154.0M136.7M18.0M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 16, 2026Insider tradeSEC
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
3 · Initial statement of ownershipNov 6, 2026Insider tradeSEC
8-K · Current reportNov 3, 2026ResultsSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 31, 2026Insider tradeSEC
8-K · Current reportAug 21, 2026Management or board changeSEC
10-Q · Quarterly reportAug 11, 2026Quarterly reportSEC
4 · Change in ownershipAug 7, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
144 · Notice of proposed saleAug 6, 2026Other filingsSEC
8-K · Current reportAug 4, 2026ResultsSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJun 25, 2026Insider tradeSEC
11-K · Annual report of an employee planJun 25, 2026Annual reportSEC
SD · Specialized disclosureMay 29, 2026ESG reportSEC
8-K · Current reportMay 22, 2026Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
10-Q · Quarterly reportMay 12, 2026Quarterly reportSEC
8-K · Current reportMay 5, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeApr 30, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 24, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 9, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 9, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 9, 2026Meeting noticeSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
8-K · Current reportMar 23, 2026Material contractSEC
424B2 · ProspectusMar 19, 2026Offer documentSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
FWP · Free writing prospectusMar 17, 2026Offer documentSEC
424B2 · ProspectusMar 16, 2026Offer documentSEC
S-3ASR · Registration statementMar 16, 2026Offer documentSEC
8-K · Current reportMar 16, 2026Current reportSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
S-8 · Registration statement for employee plansFeb 23, 2026Offer documentSEC
10-K · Annual reportFeb 23, 2026Annual reportSEC
3 · Initial statement of ownershipFeb 18, 2026Insider tradeSEC
8-K · Current reportFeb 9, 2026Acquisition or disposalSEC
8-K · Current reportFeb 9, 2026ResultsSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
8-K · Current reportJan 27, 2026Meeting outcomeSEC
425Jan 16, 2026Other filingsSEC
8-K · Current reportJan 16, 2026Current reportSEC
425Jan 13, 2026Other filingsSEC
425Jan 12, 2026Other filingsSEC
8-K · Current reportJan 12, 2026Current reportSEC
425Jan 12, 2026Other filingsSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
425Jan 5, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveDec 29, 2025Other filingsSEC
424B3 · ProspectusDec 23, 2025Offer documentSEC
S-4/A · Registration statement, amendedDec 19, 2025Offer documentSEC
425Dec 15, 2025Other filingsSEC
S-4 · Registration statementDec 11, 2025Offer documentSEC
425Nov 18, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
425Nov 10, 2025Other filingsSEC
425Nov 10, 2025Other filingsSEC
4 · Change in ownershipNov 7, 2025Insider tradeSEC
425Nov 4, 2025Other filingsSEC
10-Q · Quarterly reportNov 4, 2025Quarterly reportSEC
8-K · Current reportNov 4, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 31, 2025Big-stake noticeSEC
425Oct 14, 2025Other filingsSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
425Sep 16, 2025Other filingsSEC
425Sep 4, 2025Other filingsSEC
425Aug 28, 2025Other filingsSEC
425Aug 21, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2025Big-stake noticeSEC
425Aug 4, 2025Other filingsSEC
425Aug 4, 2025Other filingsSEC
10-Q · Quarterly reportAug 4, 2025Quarterly reportSEC
425Aug 4, 2025Other filingsSEC
8-K · Current reportAug 4, 2025ResultsSEC
425Jul 21, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
8-K · Current reportJul 14, 2025Material contractSEC
425Jul 14, 2025Other filingsSEC
425Jul 14, 2025Other filingsSEC
8-K · Current reportJul 14, 2025Current reportSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJun 26, 2025Insider tradeSEC
11-K · Annual report of an employee planJun 24, 2025Annual reportSEC
S-8 · Registration statement for employee plansJun 13, 2025Offer documentSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
8-K · Current reportMay 29, 2025Material contractSEC
8-K · Current reportMay 23, 2025Meeting outcomeSEC
SCHEDULE 13G · Big-stake noticeMay 14, 2025Big-stake noticeSEC
4 · Change in ownershipMay 14, 2025Insider tradeSEC
10-Q · Quarterly reportMay 6, 2025Quarterly reportSEC
8-K · Current reportMay 6, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 17, 2025Big-stake noticeSEC
ARS · Annual report to shareholdersApr 9, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 9, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 9, 2025Meeting noticeSEC
4 · Change in ownershipApr 8, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
10-K · Annual reportFeb 25, 2025Annual reportSEC
8-K · Current reportFeb 12, 2025ResultsSEC
4 · Change in ownershipFeb 7, 2025Insider tradeSEC
4 · Change in ownershipFeb 7, 2025Insider tradeSEC
4 · Change in ownershipFeb 7, 2025Insider tradeSEC
4 · Change in ownershipFeb 7, 2025Insider tradeSEC
8-K · Current reportJan 13, 2025Current reportSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 7, 2024Big-stake noticeSEC
8-K/A · Current report, amendedNov 1, 2024Management or board changeSEC
10-Q · Quarterly reportNov 1, 2024Quarterly reportSEC
8-K · Current reportNov 1, 2024ResultsSEC
4/A · Change in ownership, amendedOct 25, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipAug 15, 2024Insider tradeSEC
3 · Initial statement of ownershipAug 15, 2024Insider tradeSEC
8-K · Current reportAug 14, 2024Management or board changeSEC
10-Q · Quarterly reportJul 31, 2024Quarterly reportSEC
8-K · Current reportJul 31, 2024ResultsSEC
8-K · Current reportJul 18, 2024Material contractSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
3 · Initial statement of ownershipJun 25, 2024Insider tradeSEC
11-K · Annual report of an employee planJun 20, 2024Annual reportSEC
SC 13G/A · Big-stake notice, amendedJun 10, 2024Big-stake noticeSEC
4 · Change in ownershipMay 29, 2024Insider tradeSEC
SD · Specialized disclosureMay 28, 2024ESG reportSEC
8-K · Current reportMay 24, 2024Meeting outcomeSEC
4 · Change in ownershipMay 16, 2024Insider tradeSEC
144 · Notice of proposed saleMay 15, 2024Other filingsSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
10-Q · Quarterly reportMay 7, 2024Quarterly reportSEC
8-K · Current reportMay 7, 2024ResultsSEC
ARS · Annual report to shareholdersApr 12, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 12, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 12, 2024Meeting noticeSEC
4 · Change in ownershipApr 8, 2024Insider tradeSEC
4 · Change in ownershipApr 1, 2024Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Waters Corporation’s releases · as of Nov 6, 2026

Common shares
98,285,634
Fully diluted
98,285,634

Fully diluted

LineSharesAs of
Common shares98,285,634Nov 6, 2026

Share count over time

CountShares
Nov 6, 202698,285,634

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard12.3M12.5%US$5.39BSep 30, 2026
BlackRock8.64M8.8%US$3.8BSep 30, 2026
T. Rowe Price5.05M5.1%US$2.22BSep 30, 2026
State Street4.42M4.5%US$1.94BSep 30, 2026
Sun Life4.4M4.5%US$2.82BSep 30, 2026
Fidelity3.75M3.8%US$1.65BSep 30, 2026
Invesco3.33M3.4%US$1.46BSep 30, 2026
Geode Capital2.66M2.7%US$1.16BSep 30, 2026
AllianceBernstein2.52M2.6%US$1.11BSep 30, 2026
Wellington2.29M2.3%US$1.01BSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Fundsmith LLP2.27M2.3%US$996MSep 30, 2026
JPMorgan2.24M2.3%US$995MSep 30, 2026
Janus Henderson1.67M1.7%US$735MSep 30, 2026
UBS1.31M1.3%US$578MSep 30, 2026
Schroders1.17M1.2%US$514MSep 30, 2026
Principal1.13M1.1%US$494MSep 30, 2026
Franklin Templeton1.02M1.0%US$473MSep 30, 2026
Morgan Stanley997K1.0%US$438MSep 30, 2026
Northern Trust989K1.0%US$435MSep 30, 2026
Mawer Investment Management Ltd.983K1.00%US$432MSep 30, 2026
First Eagle Investment Management, LLC948K0.96%US$417MSep 30, 2026
Bank of America811K0.82%US$356MSep 30, 2026
Fundsmith Investment Services LTD.810K0.82%US$356MSep 30, 2026
Dimensional800K0.81%US$352MSep 30, 2026
Veritas Asset Management LLP765K0.78%US$336MSep 30, 2026
Schwab743K0.76%US$327MSep 30, 2026
Legal & General685K0.70%US$301MSep 30, 2026
Allspring Global Investments Holdings, LLC682K0.69%US$290MSep 30, 2026
Capital Group645K0.66%US$283MSep 30, 2026
Marshall Wace, LLP621K0.63%US$273MSep 30, 2026
Neuberger Berman Group LLC574K0.58%US$252MSep 30, 2026
Voya Investment Management LLC550K0.56%US$241MSep 30, 2026
Holocene Advisors, LP517K0.53%US$227MSep 30, 2026
HSBC503K0.51%US$221MSep 30, 2026
BNY500K0.51%US$220MSep 30, 2026
Viking Global Investors LP494K0.50%US$217MSep 30, 2026
D. E. Shaw & Co., Inc.475K0.48%US$209MSep 30, 2026
Focus Partners Wealth471K0.48%US$207MSep 30, 2026
Artisan Partners Limited Partnership460K0.47%US$202MSep 30, 2026
Goldman Sachs449K0.46%US$197MSep 30, 2026
Amundi448K0.46%US$197MSep 30, 2026
Findlay Park Partners LLP447K0.45%US$196MSep 30, 2026
DWS428K0.44%US$188MSep 30, 2026
Ameriprise417K0.42%US$183MSep 30, 2026
Beck Mack & Oliver LLC417K0.42%US$183MSep 30, 2026
Natixis Advisors, LLC413K0.42%US$181MSep 30, 2026
Mackenzie411K0.42%US$180MSep 30, 2026
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main377K0.38%US$166MSep 30, 2026
Jones Financial Companies Lllp352K0.36%US$153MSep 30, 2026
TD338K0.34%US$149MSep 30, 2026

This page holds 50 of 1,194 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund3.12M3.2%US$1.17BJun 30, 2026
Vanguard 500 Index Fund2.55M2.6%US$955MJun 30, 2026
Vanguard Mid-Cap Index Fund2.13M2.2%US$798MJun 30, 2026
T. Rowe Price Capital Appreciation Fund2.1M2.1%US$788MJun 30, 2026
iShares Core S&P 500 ETF1.35M1.4%US$506MJun 30, 2026
Fidelity 500 Index Fund1.26M1.3%US$481MMay 31, 2026
Janus Henderson Enterprise Fund1.17M1.2%US$439MJun 30, 2026
Vanguard Mid-Cap Growth Index Fund752K0.77%US$282MJun 30, 2026
MidCap Fund745K0.76%US$281MJul 31, 2026
First Eagle Global Fund700K0.71%US$264MJul 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Growth Index Fund697K0.71%US$261MJun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF694K0.71%US$260MJun 30, 2026
MFS International Intrinsic Value Fund640K0.65%US$245MMay 31, 2026
Allspring Special Mid Cap Value Fund617K0.63%US$232MJun 30, 2026
MFS Massachusetts Investors Growth Stock Fund567K0.58%US$218MMay 31, 2026
Vanguard Institutional Index Fund533K0.54%US$200MJun 30, 2026
Vanguard Windsor Fund530K0.54%US$200MJul 31, 2026
Invesco S&P 500 Equal Weight ETF513K0.52%US$194MJul 31, 2026
JNL/T. Rowe Price Capital Appreciation Fund500K0.51%US$188MJun 30, 2026
Invesco Value Opportunities Fund480K0.49%US$181MJul 31, 2026
Vanguard Value Index Fund467K0.47%US$175MJun 30, 2026
T. Rowe Price Mid-Cap Value Fund, Inc.433K0.44%US$163MJun 30, 2026
AB Large Cap Growth Fund Inc411K0.42%US$154MJun 30, 2026
Strategic Advisers U.S. Total Stock Fund406K0.41%US$156MMay 31, 2026
Putnam Large Cap Value Fund405K0.41%US$153MJul 31, 2026
iShares Russell Mid-Cap ETF404K0.41%US$152MJun 30, 2026
MFS Mid Cap Growth Fund374K0.38%US$143MMay 31, 2026
Fidelity Mid Cap Index Fund372K0.38%US$141MJul 31, 2026
Invesco Water Resources ETF358K0.36%US$135MJul 31, 2026
T. Rowe Price Capital Appreciation Equity ETF353K0.36%US$132MJun 30, 2026
MFS Mid Cap Value Fund331K0.34%US$124MJun 30, 2026
Touchstone Funds Group Trust-Touchstone Mid Cap Fund308K0.31%US$115MJun 30, 2026
Neuberger Quality Equity Fund297K0.30%US$114MMay 31, 2026
Vanguard Health Care Index Fund295K0.30%US$113MMay 31, 2026
Select Medical Technology and Devices Portfolio254K0.26%US$97.4MMay 31, 2026
First Trust Water ETF241K0.25%US$90.3MJun 30, 2026
T. Rowe Price Equity Income Fund237K0.24%US$88.9MJun 30, 2026
Invesco Discovery Mid Cap Growth Fund236K0.24%US$89MJul 31, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF234K0.24%US$87.8MJun 30, 2026
Vy(R) T. Rowe Price Capital Appreciation Portfolio222K0.23%US$83.1MJun 30, 2026
iShares Russell 1000 Value ETF219K0.22%US$82.2MJun 30, 2026
Schwab S&P 500 Index Fund219K0.22%US$82.6MJul 31, 2026
Schwab U.S. Large-Cap Growth ETF209K0.21%US$80.3MMay 31, 2026
Fidelity Total Market Index Fund185K0.19%US$71.1MMay 31, 2026
MFS Total Return Fund165K0.17%US$62MJun 30, 2026
Massachusetts Investors Trust165K0.17%US$61.9MJun 30, 2026
MFS Research Fund164K0.17%US$61.4MJun 30, 2026
The Hartford Midcap Fund162K0.17%US$61.3MJul 31, 2026
iShares S&P 500 Value ETF162K0.16%US$60.6MJun 30, 2026
FPA Crescent Fund160K0.16%US$59.9MJun 30, 2026

This page holds 50 of 823 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Kuebler Christopher A
Director
Sale3,626USD 397.94US$1.44MAug 6, 2026

Big stakes

StakeStakeSharesDateFiling
BlackRock, Inc.7.80%7.64MMar 31, 2026Schedule 13G
Vanguard Capital Management LLC7.49%7.35MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Richard H. Fearon
Other companies: CRH PLC (Non-management Director · Since at least Jan 1, 2025); Crown Holdings, Inc. (Director · Since at least Dec 13, 2019); Avient Corporation (Non-Executive Chairman · Since at least Dec 30, 2005); Hennessy Capital Investment Corp VI (Director · Sep 28, 2021 – Mar 27, 2023 · Past); Eaton Corporation, PLC (See Remarks below., Director · Feb 21, 2006 – Mar 4, 2021 · Past)
Director · Since at least Mar 27, 2023
Daniel Brennan
Other companies: Crinetics Pharmaceuticals, Inc. (Member of the Board of Directors · Since at least Nov 4, 2026); Vertex Pharmaceuticals Incorporated (Director · Since at least Oct 20, 2026); Madrigal Pharmaceuticals, Inc. (Director · Since at least Aug 1, 2025); Boston Scientific Corporation (EVP and CFO · Jan 1, 2023 – Feb 18, 2025 · Past)
Director · Since at least Nov 23, 2022
Gary Hendrickson
Other companies: James Hardie Industries plc. (Independent, Non-Executive Director · Since at least Mar 17, 2026); Azek Company Inc (Director · Since at least Jun 11, 2020); Polaris Inc. (Director · Since at least Apr 28, 2011); Stepan Company (Director · Apr 21, 2009 – Jul 29, 2011 · Past)
Director · Sep 1, 2018 – May 5, 2022 · Past
Mark P. Vergnano
Other companies: Johnson Controls International plc (Chairman of the Board; Retired Chief Executive Officer and Chairman, The Chemours Company · Since at least Sep 2, 2016); Chemours Company (the) (Director · Jun 17, 2015 – Mar 1, 2022 · Past); EIDP, Inc. USD 3.50 (Executive Vice President · Apr 29, 2010 – Jun 12, 2015 · Past)
Director · Since at least Nov 23, 2022
Sherry L. Buck
Other companies: Ball Corporation (Director · Since at least Sep 21, 2026); Lennox International, Inc. (Director · Since at least Jul 12, 2019); Libbey Inc (Vice President, CFO · Aug 1, 2012 – Aug 1, 2016 · Past)
SVP and CFO · Jan 9, 2017 – Oct 30, 2020 · Past
Belinda Hyde
Other companies: Sealed Air Corporation (Chief People Officer · Since at least Sep 9, 2024); SPX FLOW Inc (VP and CHRO · Jan 10, 2020 – Dec 22, 2020 · Past)
SVP, Global Human Resources · Jan 11, 2021 – Feb 17, 2022 · Past
Claire M. Fraser
Other companies: Seres Therapeutics, Inc. (Director · Since at least Jan 4, 2023); Becton, Dickinson and Company (Director · Since at least Nov 20, 2006)
Director · Since at least Feb 9, 2026
Edward Conard
Other companies: Sensata Technologies Holding plc (Director · Mar 10, 2010 – Mar 10, 2011 · Past); Innophos Holdings Inc (Director · Nov 2, 2006 – Nov 9, 2006 · Past)
Director · Jan 3, 2006 – Mar 31, 2023 · Past
Heather Knight
Other companies: Solventum Corporation (Chief Commercial Officer · Since at least Oct 21, 2025); Baxter International Inc. (EVP, Chief Operating Officer · Mar 1, 2023 – Mar 6, 2025 · Past)
Director · Since at least Aug 14, 2024
Joann A Reed
Other companies: American Tower Corporation (REIT) (Director · Mar 10, 2017 – Mar 10, 2025 · Past); Mallinckrodt Inc (Director · Jul 21, 2016 – Jun 16, 2022 · Past)
Director · Jan 4, 2016 – Mar 5, 2021 · Past
All 52 people
PersonSeat
John M Ballbach
Other companies: RPM International Inc. (Director · Jun 27, 2018 – Oct 31, 2023 · Past); Timken Company (the) (Director · May 8, 2012 – May 7, 2013 · Past)
Director · Oct 5, 2021 – Jan 3, 2022 · Past
Linda Baddour
Other companies: CryoPort, Inc. (Board Member · Since at least Mar 15, 2021); PRA Health Sciences Inc (Executive VP & CFO · Nov 12, 2014 – Jan 16, 2018 · Past)
Director · Since at least Sep 1, 2018
Amol Chaubal
Other companies: Quanterix Corporation (Chief Financial Officer · Apr 12, 2019 – May 3, 2021 · Past)
SVP & Chief Financial Officer · Since at least May 12, 2021
Daniel J Welch
Other companies: Evergreen Solar Inc (VP and GM - US Manufacturing · Sep 30, 2010 – Mar 1, 2011 · Past)
SVP Global Operations · Jul 9, 2020 – Feb 23, 2022 · Past
John A Ornell
Other companies: Bruker Corporation (Director · Since at least Aug 19, 2015)
CFO · Aug 6, 2010 – Dec 6, 2013 · Past
Jonathan M Pratt
Other companies: SPX FLOW Inc (Director · Aug 20, 2020 – Apr 5, 2022 · Past)
SVP Waters Division · Sep 3, 2019 – Oct 10, 2023 · Past
Laurie H M D Glimcher
Other companies: Analog Devices, Inc. (Director · Aug 18, 2020 – Mar 12, 2025 · Past)
Director · Nov 1, 2019 – Jan 2, 2020 · Past
Michael J Berendt
Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026)
Director · May 15, 2013 – Aug 13, 2021 · Past
Thomas P. Salice
Other companies: Mettler-Toledo International, Inc. (Director · Since at least Jun 5, 2019)
Director · Nov 1, 2019 – Jan 3, 2022 · Past
Wei Jiang
Other companies: STAAR Surgical Company (Director · Since at least Mar 12, 2024)
Director · Since at least Jul 14, 2021
Allan JaenickeSVP, Transformation · Since at least Nov 5, 2026
Arthur G CaputoEVP and President, Waters Div · Dec 31, 2005 – Dec 6, 2016 · Past
Brian K MazarSVP · Dec 31, 2005 – Dec 31, 2005 · Past
Brook ColangeloSVP & Chief Information Officer · Since at least Nov 5, 2026
Caspar TudorHead of Investor Relations · Since at least Nov 3, 2026
Christopher A. KueblerDirector · Since at least Jan 2, 2024
Christopher J OConnellCEO and President · Dec 5, 2017 – Jul 31, 2020 · Past
Dan BrennanSince at least Nov 4, 2026
Daniel RushSVP, Global Research & Strategy · Since at least Nov 5, 2026
David TerriccianoSVP, Global Operations · Feb 10, 2016 – Feb 28, 2018 · Past
Elizabeth B RaeSVP, Global HR · May 23, 2006 – Aug 20, 2020 · Past
Flemming OrnskovDirector · Since at least Jun 22, 2017
Flemming ØrnskovChair of the Board · Since at least Feb 9, 2026
Francis KimSVP Global Operations · Mar 19, 2018 – Mar 2, 2020 · Past
Fraser McLeodChief Executive Officer · Since at least Mar 10, 2026
Ian KingSVP, Global Products · Feb 10, 2016 – Mar 1, 2021 · Past
Janice FoleySenior Public Relations Manager, Corporate Communications · Apr 1, 2025 – Nov 4, 2026 · Past
Jianqing BennettSVP, Waters Advanced Diagnostics Division · Since at least May 1, 2021
Joyce YoonSVP, Waters Materials Sciences Division · Since at least Nov 5, 2026
Keeley AlemanSVP, General Counsel and Head of Global Human Resources · Since at least Oct 12, 2020
Kristen GarveySVP, Global Communications · Since at least Nov 5, 2026
Mark GladwellSVP, Global Operations · Since at least Nov 5, 2026
Mark T BeaudouinSVP and General Counsel · Dec 5, 2017 – Nov 15, 2019 · Past
Michael C HarringtonSVP, Global Markets · Dec 5, 2017 – Mar 1, 2021 · Past
Michael F SilveiraVP, Corporate Controller · Aug 23, 2013 – May 3, 2022 · Past
Pearl S. HuangPresident, Dunad Therapeutics · Since at least Jan 1, 2021
Robert L Carpio IIISVP Waters Analytical Sciences · Since at least Jun 24, 2024
Rohit KhannaSVP, Applied Technology · Feb 10, 2016 – Dec 29, 2017 · Past
Steve ConlySVP, Waters Biosciences Division · Since at least Oct 19, 2026
Tina WuSVP, Waters Analytical Sciences Division · Since at least Oct 28, 2026
Tong WuSVP Waters Analytical Sciences · Since at least Aug 21, 2026
Udit BatraPresident · Since at least Sep 1, 2020

Open People

Log in to ask 6ix AI your own questions about Waters Corporation.